MiMedx Group, Inc. (MDXG)

MiMedx Group Income Statement

Financials in millions USD. Fiscal year is January - December.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Jun 30, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Revenue	363.77	348.88	321.48	267.84	242.02	248.23
Revenue Growth (YoY)	6.85%	8.52%	20.03%	10.67%	-2.50%	-17.05%
Cost of Revenue	67.47	60.07	54.63	48.32	39.63	39.33
Gross Profit	296.3	288.81	266.84	219.53	202.39	208.9
Selling, General & Admin	239.37	216.39	216.3	220.85	198.64	240.49
Research & Development	13.12	12.34	12.67	12.7	9.93	11.72
Operating Expenses	253.08	229.5	229.73	234.25	209.39	253.28
Operating Income	43.23	59.31	37.12	-14.73	-7	-44.37
Interest Expense	-2	-3.94	-6.58	-5.05	-4.98	-8.27
Interest & Investment Income	3.92	2.93	0.12	0.03	-	0.33
Other Non Operating Income (Expenses)	-0.48	-0.57	-0.03	-0	-0.02	-0
EBT Excluding Unusual Items	44.68	57.74	30.63	-19.75	-12	-52.32
Asset Writedown	-0.39	-0.45	-	-	-0.05	-1.03
Other Unusual Items	-	-	-	-	-	-8.2
Pretax Income	44.29	57.29	30.63	-19.75	-12.05	-61.54
Income Tax Expense	12.33	15.3	-36.81	0.21	0.25	-12.26
Earnings From Continuing Operations	31.96	42	67.44	-19.95	-12.3	-49.28
Earnings From Discontinued Operations	0.22	0.42	-9.21	-10.24	2.02	-
Net Income	32.17	42.42	58.23	-30.2	-10.29	-49.28
Preferred Dividends & Other Adjustments	-	-	11.64	6.58	6.14	34.04
Net Income to Common	32.17	42.42	46.59	-36.78	-16.42	-83.33
Net Income Growth	-63.81%	-27.15%	-	-	-	-
Shares Outstanding (Basic)	147	147	116	113	110	108
Shares Outstanding (Diluted)	149	149	146	113	110	108
Shares Change (YoY)	-8.26%	2.11%	29.27%	2.32%	1.94%	1.23%
EPS (Basic)	0.22	0.29	0.40	-0.33	-0.15	-0.77
EPS (Diluted)	0.21	0.28	0.36	-0.33	-0.15	-0.77
EPS Growth	-60.29%	-22.18%	-	-	-	-
Free Cash Flow	57.13	64.51	24.79	-19.41	-5.2	-34.49
Free Cash Flow Per Share	0.38	0.43	0.17	-0.17	-0.05	-0.32
Gross Margin	81.45%	82.78%	83.00%	81.96%	83.63%	84.16%
Operating Margin	11.88%	17.00%	11.54%	-5.50%	-2.89%	-17.88%
Profit Margin	8.84%	12.16%	14.49%	-13.73%	-6.78%	-33.57%
Free Cash Flow Margin	15.71%	18.49%	7.71%	-7.25%	-2.15%	-13.89%
EBITDA	53.74	65.35	40.54	-10.68	-1.82	-37.52
EBITDA Margin	14.77%	18.73%	12.61%	-3.99%	-0.75%	-15.11%
D&A For EBITDA	10.52	6.04	3.43	4.05	5.18	6.86
EBIT	43.23	59.31	37.12	-14.73	-7	-44.37
EBIT Margin	11.88%	17.00%	11.54%	-5.50%	-2.89%	-17.88%
Effective Tax Rate	27.84%	26.70%	-	-	-	-
Advertising Expenses	-	0.6	0.6	0.2	0.1	0.1

Updated Jul 30, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.

SEC Filings: 10-K · 10-Q